+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic BCG Vaccine Market by Route of Administration (Intradermal Injection, Intravesical Administration), Application (Bladder Cancer, Melanoma, Type 1 Diabetes), End User - Global Forecast 2025-2030- Product Image
Therapeutic BCG Vaccine Market by Route of Administration (Intradermal Injection, Intravesical Administration), Application (Bladder Cancer, Melanoma, Type 1 Diabetes), End User - Global Forecast 2025-2030- Product Image
Sale

Therapeutic BCG Vaccine Market by Route of Administration (Intradermal Injection, Intravesical Administration), Application (Bladder Cancer, Melanoma, Type 1 Diabetes), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986049
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The therapeutic BCG vaccine market is rapidly evolving as innovative clinical applications, technological advancements, and regulatory momentum converge to reshape immunotherapy strategies in oncology and autoimmune disease management. Senior leaders navigating this sector must comprehend shifting biomedical paradigms, supply chain dependencies, and the practical imperatives that drive competitive advantage across global regions.

Market Snapshot: Growth of the Therapeutic BCG Vaccine Market

The therapeutic BCG vaccine market is experiencing consistent expansion, with recent analysis revealing robust year-over-year growth. Strong adoption stems from the vaccine’s expanding roles in complex indications such as oncology and autoimmune therapies. The continued positive outlook is driven by a combination of scientific breakthroughs, increased investment, and supportive regulatory pathways, reinforcing the market’s strategic importance to key stakeholders.

Scope & Segmentation of Therapeutic BCG Vaccine Applications

  • Route of Administration: Intradermal injection and intravesical administration are the two principal delivery methods, tailored to either systemic immune activation or localized treatment efficacy.
  • Application: Major clinical domains include bladder cancer (with specific attention to carcinoma in situ and non-muscle invasive cases), melanoma (cutaneously and mucosally categorized), and type 1 diabetes as a prominent non-oncological target.
  • End User: Ambulatory surgical centers, oncology and urology clinics, and hospital settings are the primary healthcare environments facilitating vaccine deployment and patient monitoring.
  • Geographic Regions: The analysis covers critical territories: the Americas (United States—focusing on states such as California, Texas, New York, among others—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Russia, key Middle Eastern and African states), and Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Leading Industry Participants: Top companies featured include Merck & Co., Inc., Sanofi S.A., Serum Institute of India Private Limited, Statens Serum Institut, Japan BCG Laboratory Co., Ltd., InterVax Inc., Laboratorios Reig Jofre S.A., Shanghai Institute of Biological Products Co., Ltd., Instituto Butantan, and Jiangxi Institute of Biological Products Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Therapeutic BCG vaccines have transitioned from traditional prophylactic use to integral roles in immunotherapeutic regimens for cancers and autoimmune disorders.
  • Partnerships between biotechnology innovators and established pharmaceutical manufacturers are accelerating clinical validation, operational scale-up, and regulatory submissions across markets.
  • Enhanced formulation strategies are leading to improved patient outcomes and reduced undesirable immunological reactions.
  • Regional market dynamics, particularly in Asia-Pacific and the Americas, are defined by diverse reimbursement landscapes, regulatory timelines, and technology transfer patterns.
  • Cross-sector collaboration, notably between academic research and industry, is strengthening translational research pipelines and market responsiveness.

Tariff Impact: Navigating U.S. 2025 Adjustments

Upcoming 2025 United States tariff changes are instigating profound adjustments throughout therapeutic BCG vaccine supply chains. Manufacturers are reassessing procurement models, deepening domestic supplier relationships, and exploring vertical integration to mitigate cost volatility. Simultaneously, global clinical collaborations are being restructured, emphasizing risk management and contingency planning to navigate customs delays and preserve trial integrity. Policy dialogue is active, aiming for tariff classifications that recognize the vaccine’s critical public health role and safeguard immunotherapy innovation pipelines.

Methodology & Data Sources

This research leverages a mixed-methods approach: secondary data synthesis from literature, regulatory filings, and patent databases is integrated with primary interviews involving key opinion leaders, clinicians, and manufacturing experts. Insights are triangulated against proprietary clinical trial and supply chain data, ensuring comprehensive, reliable market intelligence that aligns qualitative and quantitative findings.

Why This Report Matters for Strategic Leaders

  • Informs executive decision-making with actionable insights on technological, regulatory, and clinical trends shaping the therapeutic BCG vaccine landscape.
  • Supports the formulation of resilient procurement, manufacturing, and partnership strategies in response to shifting global trade and policy frameworks.

Conclusion

The therapeutic BCG vaccine sector is undergoing significant transformation, presenting substantial opportunities for those able to anticipate clinical, operational, and regulatory changes. Forward-thinking organizations can strengthen their market position by leveraging up-to-date intelligence and fostering cross-sector innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising clinical adoption of intravesical BCG formulations for bladder cancer immunotherapy breakthroughs
5.2. Development of recombinant BCG strains enhancing antigen presentation and immunogenicity in tuberculosis prevention
5.3. Expansion of combination therapies pairing BCG vaccines with checkpoint inhibitors to elevate patient response rates
5.4. Regulatory pathways streamlining approval of novel therapeutic BCG vaccine indications beyond urological applications
5.5. Impact of global BCG vaccine shortages driving adoption of biosimilar and alternative immunotherapeutic products
5.6. Advances in BCG vaccine lyophilization and stabilization methods to extend shelf life in emerging regions
5.7. Investment trends focusing on next generation BCG vaccine platforms utilizing genetic engineering for targeted delivery
5.8. Strategic collaborations between biotechnology firms and academic institutions accelerating BCG immunotherapy innovation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Therapeutic BCG Vaccine Market, by Route of Administration
8.1. Introduction
8.2. Intradermal Injection
8.3. Intravesical Administration
9. Therapeutic BCG Vaccine Market, by Application
9.1. Introduction
9.2. Bladder Cancer
9.2.1. Carcinoma In Situ
9.2.2. Non-Muscle Invasive
9.3. Melanoma
9.3.1. Cutaneous Melanoma
9.3.2. Mucosal Melanoma
9.4. Type 1 Diabetes
10. Therapeutic BCG Vaccine Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Oncology Clinics
10.3.2. Urology Clinics
10.4. Hospitals
11. Americas Therapeutic BCG Vaccine Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Therapeutic BCG Vaccine Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Therapeutic BCG Vaccine Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Merck & Co., Inc.
14.3.2. Sanofi S.A.
14.3.3. Serum Institute of India Private Limited
14.3.4. Statens Serum Institut
14.3.5. Japan BCG Laboratory Co., Ltd.
14.3.6. InterVax Inc.
14.3.7. Laboratorios Reig Jofre S.A.
14.3.8. Shanghai Institute of Biological Products Co., Ltd.
14.3.9. Instituto Butantan
14.3.10. Jiangxi Institute of Biological Products Co., Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. THERAPEUTIC BCG VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. THERAPEUTIC BCG VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. THERAPEUTIC BCG VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. THERAPEUTIC BCG VACCINE MARKET: RESEARCHAI
FIGURE 22. THERAPEUTIC BCG VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 23. THERAPEUTIC BCG VACCINE MARKET: RESEARCHCONTACTS
FIGURE 24. THERAPEUTIC BCG VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THERAPEUTIC BCG VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRADERMAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRAVESICAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY INTRAVESICAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CARCINOMA IN SITU, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CARCINOMA IN SITU, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY NON-MUSCLE INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY NON-MUSCLE INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CUTANEOUS MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CUTANEOUS MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MUCOSAL MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MUCOSAL MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 77. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 82. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 83. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 84. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 85. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 88. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 89. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 95. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 96. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 97. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 156. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 158. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 159. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 168. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 169. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 170. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 171. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 192. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 193. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 194. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 195. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 198. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 199. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 204. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 205. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 206. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 207. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 252. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 253. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 254. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 255. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 276. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 277. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 278. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 279. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 288. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 289. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 290. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 291. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 319. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2018-2024 (USD MILLION)
TABLE 324. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY BLADDER CANCER, 2025-2030 (USD MILLION)
TABLE 325. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2018-2024 (USD MILLION)
TABLE 326. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY MELANOMA, 2025-2030 (USD MILLION)
TABLE 327. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 330. EGYPT THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 331. TURKEY THERAPEUTIC BC

Samples

Loading
LOADING...

Companies Mentioned

  • Merck & Co., Inc.
  • Sanofi S.A.
  • Serum Institute of India Private Limited
  • Statens Serum Institut
  • Japan BCG Laboratory Co., Ltd.
  • InterVax Inc.
  • Laboratorios Reig Jofre S.A.
  • Shanghai Institute of Biological Products Co., Ltd.
  • Instituto Butantan
  • Jiangxi Institute of Biological Products Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.17 Million
Forecasted Market Value ( USD ) by 2030 $ 78.66 Million
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Therapeutic BCG Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Therapeutic BCG Vaccines Market Report 2025 - Product Image

Therapeutic BCG Vaccines Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Global BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Bacillus Calmette-Guérin (BCG) Vaccines - Global Strategic Business Report - Product Image

Bacillus Calmette-Guérin (BCG) Vaccines - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology - Product Image

BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology

  • Report
  • 96 Pages
  • Global
From

About the BCG Vaccine Market

The BCG Vaccine is a vaccine used to protect against tuberculosis (TB). It is the only vaccine available for TB prevention and is used in many countries around the world. The BCG Vaccine market is a subset of the larger Vaccines market, which includes a wide range of vaccines used to prevent and treat various diseases. The BCG Vaccine market is largely driven by the prevalence of TB in different countries, as well as the availability of the vaccine. The BCG Vaccine market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Serum Institute of India. Other companies in the market include Emergent BioSolutions, Bavarian Nordic, and Valneva. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.